mattisDr. Steven Mattis, President

Steven Mattis, Ph.D., is President of the Juvenile Bipolar Research foundation. He received his Ph.D. from Columbia University. Dr. Mattis is an internationally known neuropsychologist and recognized as a leading figure in the development of the field of clinical neuropsychology in the United States. He has been on the Board and President of the International Neuropsychological Society; on the Board and President of the Clinical Neuropsychology Division of the American Psychological Association; A Fellow of the American Psychological Association; Founding member of the Board and President of the American Board of Clinical Neuropsychology, the Specialty credentialing agent of the American Board of Professional Psychology; and on the Board and President of the American Board of Professional Psychology. He is currently Clinical Professor of Psychology, Department of Psychiatry, New York Presbyterian Weill Cornell Medical Center and in private practice at Mattis & Luck Center for Neuropsychological Services. Dr. Mattis had been Chief of Neuropsychology in the Department of Neurology, Albert Einstein School of Medicine, Chief of Neuropsychology, Department of Psychiatry, Weill Cornell Medical Center, and Chief Psychologist at Hillside Hospital-Northshore Medical System. He has over 70 articles in peer reviewed journals, multiple chapters in edited books, and is the author of the Dementia Rating Scale. Dr. Mattis has been a co-editor and reviewer for multiple professional journals and served on the Research Review Board for the Human Development and Aging section of the National Institutes of Health.

For the last 10 years, Dr. Mattis has focused his research and clinical interests on the neuropsychology of psychiatric mood disorders. In collaboration with Drs. Papolos and others, he has published several articles delineating a phenotype of juvenile bipolar disorder which has been termed Fear of Harm syndrome.

dr-papolosDr. Demitri Papolos, Director of Research

Demitri Papolos, M.D. is Co-director of the Program in Behavioral Genetics and associate professor of clinical psychiatry at the Albert Einstein College of Medicine in New York City. He has been a recipient of an NIMH Physician/ Scientist Award as well as a NARSAD Independent Investigator Award, and his research findings have been published in the American Journal of Psychiatry, the American Journal of Human Genetics, Molecular Psychiatry, and the Journal of Affective Disorders, among others.

In 2001, Dr. Papolos became the director of research of the Juvenile Bipolar Research Foundation (JBRF) where he established a consortium of clinical and basic researchers from medical centers across the country in order to focus on the root causes of childhood-onset bipolar disorder. These investigators have conducted studies in the fields of phenomenology, neuroimaging, chronobiology, neuropsychological testing, and molecular genetics. Recent work published by Dr. Papolos, and his colleagues may be viewed here.

Because thousands of families have completed the online screening instruments developed by Dr. Papolos, JBRF has been able to assemble the largest clinical database in the world of children with, or at risk for, bipolar disorder. Moreover, these diagnostic instruments are available in multiple languages and are being used by clinics in this country and abroad.

Dr. Herbert M. Lachman

Dr. Lachman is a professor in the Department of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine. He also holds joint appointments in the departments of Medicine, Genetics and Neuroscience. Dr. Lachman became of a member of the JBRF Board of Directors in 2011. He is a co-author of 90 scientific papers, book chapters and reviews. He has also written a book for laymen exploring the role of Darwinian selection in human disease called, “Battle of the Genomes: The Struggle For Survival in a Microbial World.” Dr. Lachman’s primary research interests are the molecular and genetic basis of bipolar disorder and schizophrenia, and the development of patient-specific induced pluripotent stem cell (iPSC) technology to model neuropsychiatric disorders in the laboratory. iPSCs are derived from skin cells and can be turned into human neurons, which can then be studied in animal-free systems. iPSC technology is a very promising tool for developing new drugs for neuropsychiatric disorders. In addition to research, Dr. Lachman sees patients in the Division of Substance Abuse and is very involved in student education at Einstein where he teaches human genetics to first year medical students, and graduate students in the Sue Golding Graduate Division and Clinical Research Training Program. He has received two teaching awards at Einstein. He is also a grand rounds speaker and gives a lecture on the role of genes in criminal behavior at Fordham Law School.

Dr. Lachman is board certified in Internal Medicine and is a member of the American Association for the Advancement of Science and the International Society of Psychiatric Genetics. He is an editor for the Open Psychiatry Journal and the Frontiers in Behavioral Neuroscience and has reviewed papers for some of the top psychiatry and neuroscience journals, including Molecular Psychiatry, Biological Psychiatry, American Journal of Medical Genetics, Human Molecular Genetics and the Archives of General Psychiatry. He has also reviewed grants for 20 NIH study sections. Dr. Lachman lives in Manhattan with his wife and two children.


John Bernardo, Treasurer

John M. Bernardo, CPA is the Treasurer and member of the Board of Directors of the Juvenile Bipolar Research Foundation, Inc. He received his BBA in Accounting from Siena College in 1983. John is a member of the American Institute of Certified Public Accountants and the NYS Society of CPA’s. In addition to his many years of practice in the accounting and finance fields, John is or has served as the Chief Financial Officer and / or Chief Operating Officer of many privately held enterprises involved in the fields of telecommunications, billing services, electronic loyalty programs, start-up consulting and real estate. John is a former Supervisor of the Town of Union and current Deputy County Executive for Broome County, both located in upstate New York. He is a past Treasurer and Board Member of the SUNY Health Science Center (Upstate Medical Center) Foundation, Inc. and is currently serving as a Board Member of the Broome County Industrial Development Agency (“IDA”) and the Broome County Local Development Corporation (“LDC”.)

Sarah Bowman-Deutsch Post DHL (2)(1)Sarah Bowman, Director

Sarah Bowman is Vice President of Investor Relations (IR) at Deutsche Post DHL, a German-listed, Eurostoxx 50 company and global leader in the logistics industry. Sarah is responsible for US investor relations and is a senior member of the award winning DP DHL IR team. In 2015 she was ranked Best IR for a European Company in the US market by IR Magazine.

After nearly 20 years of international, institutional equity sales in positions as Head of Sales, research sales and corporate access management, Sarah transitioned to IR in 2010. With her profound understanding of investor needs, investor relations best practice and cross-cultural communications, she brings a unique perspective to the joint “internal and external” communication role that is IR. She served and continues to serve on the Annual Conference Planning Committee for the National Investor Relations Institute, and is a frequent conference speaker at national and global IR events. Her healthcare related interests include supporting the American Heart Association and American Liver Association for which she fundraises and participates in awareness-related speaking events.

Sarah holds a BA in Philosophy and Economics from Columbia University and is quadralingual.

Cleland C. Landolt, M.D., FACS, FACC, FACP, Director

In Memory of Dr. Cleland C. Landolt

Dr. Landolt brings extensive experience to his corporate partners as a life sciences industry C-level executive and advisor following a successful clinical career as a cardiothoracic and vascular surgeon. In various corporate roles, he has run strategic and business development groups, and served as Chief Medical Officer or Chief Operating Officer of several medical companies. This includes previous Chief Medical Officer appointments at Berkeley HeartLab, diaDexus, Singulex, and Novellus Research Sites. With an expertise in developing emerging technologies, especially in the cardiometabolic space, he has been particularly focused on commercialization efforts targeting wireless and Software as a Service (SaaS) cloud-based health care and life science platforms. He also is a Trustee on the Board of Trustees of the Ronald McDonald House Charities of San Diego. Dr. Landolt completed his secondary education at Phillips Exeter Academy, and his undergraduate studies at Harvard College, graduating Cum Laude in Biology. He received his M.D. from Weill Cornell University Medical College. Prior to his transition into industry, he led successful cardiovascular and thoracic surgical practises on the East Coast and the West Coast, preceded by teaching appointments at Harvard University, University of California San Francisco, and Emory University.

John Cosentino

John is a founding partner of the Ironwood Manufacturing Fund, a private equity firm specializing in control investments in manufacturing, distribution and service companies. He has been an individual investor leading several investments in privately held companies and is an experienced executive who has held senior management positions with Danaher Corporation, Rau Fastener, Stanley, Black & Decker and several divisions of United Technologies. John presently leads or serves on the boards of Sturm, Ruger & Co., Simonds International Inc., Whitcraft LLC, Habco Industries LLC, and Addaero LLC. He holds an A.B. cum laude in economics from Harvard and an M.B.A. from the Wharton School of the University of Pennsylvania.